cPLA Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of cPLA Antibodies for various research applications. cPLA Antibodies are optimized for techniques such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cytosolic phospholipase A2 (cPLA) plays a crucial role in the metabolism of phospholipids, leading to the release of arachidonic acid, a precursor for bioactive lipids involved in inflammation and cell signaling. The regulation of cPLA activity is essential for various physiological processes, including immune response and cellular signaling pathways. Understanding the function of cPLA is vital for elucidating its role in diseases such as cancer and cardiovascular disorders. Research into cPLA has revealed significant insights into cellular mechanisms and potential therapeutic targets. Advanced detection methods using monoclonal antibodies enable precise identification and characterization of cPLA in experimental settings. The high specificity of Santa Cruz Biotechnology monoclonal antibodies supports researchers worldwide in advancing scientific understanding of cPLA and its impact on human health.